Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2011-04-08 | Thomas F. Deuel, M.D. has served as a director of the Company since April 2010. Dr. Deuel is currently a Professor of Molecular and Experimental Medicine...Dr. Deuel brings to the Board many years of experience with scientific and medical research...The Board has nominated and recommends that the stockholders elect Thomas F. Deuel...Director...Age 75...Total Director Compensation 264,543. |
| 2012-04-06 | Thomas F. Deuel has served as a director of the Company since April 2010...Dr. Deuel is a member of the Institute of Medicine at the National Academy of Sciences...DIRECTOR COMPENSATION FOR FISCAL YEAR ENDED DECEMBER 31, 2011: Thomas F. Deuel Fees Earned or Paid in Cash ($) 85,859, Stock Awards ($) 75,001, Option Awards ($) 75,003, Total ($) 235,863. |
| 2013-10-11 | The Compensation Committee currently consists of Dr. Deuel and Dr. Young, each of whom will not stand for re-election at the 2013 Annual Meeting. ... The charter of the Compensation Committee may be found on our website at www.enzon.com. |
Data sourced from SEC filings. Last updated: 2025-10-11